旅行疫苗市场规模、份额和成长分析（按疫苗类型、疾病、旅行者类型和地区划分）－2025-2032年产业预测

全球旅行疫苗市场预计在 2023 年达到 41 亿美元，从 2024 年的 43.1 亿美元成长到 2032 年的 64.7 亿美元，在预测期（2025-2032 年）内复合年增长率为 5.2%。

全球旅行疫苗市场正经历显着成长，这主要受多种因素影响，包括供需关係。休閒、商务和教育等国际旅行的增加，导致旅客接触地方性感染疾病的机会增多，进一步强化了疫苗接种的需求。旅游业，尤其是生态旅游和前往偏远地区的探险旅行，凸显了疫苗接种的重要性。公众和政府对感染疾病疫情的日益关注也推动了疫苗需求。许多国家要求入境时必须提供疫苗接种证明等监管规定，提高了疫苗接种的合规性，并促进了市场需求。疫苗研发的创新，特别是mRNA和重组技术，提高了疫苗的有效性和生产速度，增加了对这些产品的依赖。此外，医疗保健成本的上涨以及公共卫生机构所进行的旅客和疫苗接种教育推广工作，也创造了新的市场机会。

全球旅行疫苗市场驱动因素

全球旅行疫苗市场的主要驱动力是国际旅行和旅游业的蓬勃发展，这显着增加了人们感染疾病的风险。随着越来越多的人因休閒、商务和留学等原因进行国际旅行，采取预防性健康措施（包括接种疫苗）来保护自身健康变得至关重要。民众对疫苗可预防疾病的认识不断提高，以及卫生部门的建议，进一步推动了旅游疫苗的需求。此外，全球化、旅游目的地多样化以及各地不同的卫生法规等因素，也提高了人们对行前接种疫苗的意识，从而进一步促进了旅游疫苗市场的成长。

限制全球旅行疫苗市场的因素

全球旅行疫苗市场的主要限制因素之一是各国法规结构和核准流程的差异。每个国家都制定了自己的疫苗接种指南，这可能导致疫苗的供应和接受度有差异。此外，基于错误讯息和文化信念的疫苗犹豫也可能阻碍市场成长。旅行限制和地缘政治因素也可能限制某些地区的疫苗供应。由于旅行者寻求疫苗安全性和有效性的保证，监管实践的不一致可能会在全球范围内阻碍人们对旅行疫苗的信任和接受度。

全球旅行疫苗市场趋势

先进疫苗技术的整合正在改变全球旅行疫苗市场。 mRNA、重组和单剂量平台等创新技术能够快速应对新出现的全球健康威胁，同时提高疫苗效力和分发效率。继mRNA平台在新冠疫情期间取得成功后，主要企业正大力投资研发新型疫苗和联合疫苗，以满足现代旅客不断变化的需求。这种前瞻性的方法不仅满足了当前的医疗保健需求，也预见了未来疫苗监管政策的变化，从而确保了市场的持续成长和适应能力。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术评估
• 监管环境

旅行疫苗市场规模（依疫苗类型划分）及复合年增长率（2025-2032 年）

• 市场概览
• 单剂疫苗
• 联合疫苗

旅行疫苗市场规模（按疾病划分）及复合年增长率（2025-2032 年）

• 市场概览
• 甲型肝炎
• B型肝炎
• 伤寒
• 黄热病
• 狂犬病
• 脑膜炎奈瑟菌
• 日本脑炎
• 麻疹和腮腺炎
• 其他的

旅行疫苗市场规模（依旅行者类型划分）及复合年增长率（2025-2032 年）

• 市场概览
• 海外旅客
• 入境旅客
• 商务旅行
• 休閒旅游

旅行疫苗市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2024 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2024 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2022-2024年营收年比比较

主要企业简介

• GlaxoSmithKline plc
• Sanofi Pasteur
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Abbott Laboratories
• ALK-Abello A/S
• Bavarian Nordic A/S
• CSL Limited
• AstraZeneca plc
• Dynavax Technologies
• Emergent BioSolutions, Inc.
• Valneva SE
• Takeda Pharmaceutical Company
• Serum Institute of India Pvt. Ltd.
• Bharat Biotech International Ltd.
• Altimmune, Inc.
• LG Chem Ltd.（Life Sciences）
• Hualan Biological Engineering Inc.
• Mitsubishi Tanabe Pharma Corporation

结论与建议

Global Travel Vaccines Market size was valued at USD 4.1 billion in 2023 and is poised to grow from USD 4.31 billion in 2024 to USD 6.47 billion by 2032, growing at a CAGR of 5.2% during the forecast period (2025-2032).

The global travel vaccines market is experiencing significant growth propelled by various factors influencing both demand and supply dynamics. Increased global travel for leisure, business, and education has intensified the need for vaccinations, as travelers encounter region-specific infections. The thriving tourism sector, particularly eco-tourism and adventure travel to remote locations, underscores the critical nature of vaccination. Heightened public and governmental awareness of infectious disease outbreaks further drives vaccine demand. Regulatory mandates in numerous countries necessitating proof of vaccination for entry enhance compliance and market demand. Innovations in vaccine development, particularly through mRNA and recombinant technologies, improve efficacy and expedite creation, fostering greater reliance on these products. Additionally, rising healthcare costs and initiatives by public health agencies to educate travelers and promote immunization open new market opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Travel Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Travel Vaccines Market Segments Analysis

Global Travel Vaccines Market is segmented by Vaccine Type, Disease, Traveler Type and region. Based on Vaccine Type, the market is segmented into Mono Vaccines and Combination Vaccines. Based on Disease, the market is segmented into Hepatitis A, Hepatitis B, Typhoid, Yellow Fever, Rabies, Meningococcal, Japanese Encephalitis, Measles & Mumps and Others. Based on Traveler Type, the market is segmented into Outbound Travelers, Inbound Travelers, Business Travel and Leisure Travel. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Travel Vaccines Market

A key market driver for the global travel vaccines market is the increasing international travel and tourism, which has significantly enhanced the risk of exposure to infectious diseases. As more individuals embark on international trips for leisure, business, or study, the need for preventative healthcare measures, including vaccinations, becomes paramount to safeguard health. Rising public awareness regarding vaccine-preventable diseases and recommendations from health authorities further propel the demand for travel vaccines. Additionally, factors such as globalization, diverse travel destinations, and varying health regulations strengthen the inclination for immunization prior to travel, fostering growth in the travel vaccines market.

Restraints in the Global Travel Vaccines Market

One key market restraint for the global travel vaccines market is the varying regulatory frameworks and approval processes across different countries. Each nation establishes its own guidelines for vaccine administration, which can lead to discrepancies in availability and acceptance. Additionally, the hesitance towards vaccinations due to misinformation or cultural beliefs can further inhibit market growth. Travel restrictions and geopolitical factors can also limit the accessibility of vaccines in certain regions. As travelers seek assurance regarding vaccine safety and efficacy, inconsistent regulatory practices may hinder the overall confidence and uptake of travel vaccines globally.

Market Trends of the Global Travel Vaccines Market

The Global Travel Vaccines market is witnessing a significant transformation driven by the integration of advanced vaccine technologies. Innovations such as mRNA, recombinant, and single-dose platforms are enabling faster responses to emerging global health threats while enhancing vaccine efficacy and improving distribution efficiencies. The success of mRNA platforms, highlighted during the COVID-19 pandemic, has prompted major companies to invest heavily in research for new and combination travel vaccines tailored to the evolving demands of contemporary travelers. This proactive approach not only addresses current healthcare needs but also anticipates future vaccine regulation changes, positioning the market for sustained growth and adaptability.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Travel Vaccines Market Size by Vaccine Type & CAGR (2025-2032)

• Market Overview
• Mono Vaccines
• Combination Vaccines

Global Travel Vaccines Market Size by Disease & CAGR (2025-2032)

• Market Overview
• Hepatitis A
• Hepatitis B
• Typhoid
• Yellow Fever
• Rabies
• Meningococcal
• Japanese Encephalitis
• Measles & Mumps
• Others

Global Travel Vaccines Market Size by Traveler Type & CAGR (2025-2032)

• Market Overview
• Outbound Travelers
• Inbound Travelers
• Business Travel
• Leisure Travel

Global Travel Vaccines Market Size & CAGR (2025-2032)

• North America (Vaccine Type, Disease, Traveler Type)
  • US
  • Canada
• Europe (Vaccine Type, Disease, Traveler Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Disease, Traveler Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Disease, Traveler Type)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Disease, Traveler Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• GlaxoSmithKline plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Pasteur
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ALK-Abello A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valneva SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech International Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altimmune, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LG Chem Ltd. (Life Sciences)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mitsubishi Tanabe Pharma Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations